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To make timing of artiﬁcial insemination (AI) relative to ovulation less critical, methods for
prolonging shelf life of spermatozoa in vivo after AI have been attempted to be developed.
Encapsulation of sperm cells is a documented technology, and recently, a technology inwhich
sperm cells are embedded in alginate gel has been introduced and commercialized. In this
study, standard processed semen with the Biladyl extender (control) was compared with
semen processed by sperm immobilization technology developed by SpermVital AS in a blind
ﬁeld trial. Moreover, in vitro acrosome and plasma membrane integrity was assessed and
comparedwith AI fertility data for possible correlation. Semen from 16 Norwegian Red young
bulls with unknown fertility was collected and processed after splitting the semen in two
aliquots. These aliquots were processed with the standard Biladyl extender or the SpermVital
extender to a ﬁnal number of 12  106 and 25  106 spermatozoa/dose, respectively. In total,
2000 semen doses were produced from each bull, divided equally by treatment. Artiﬁcial
insemination doses were set up to design a blinded AI regime; 5 þ 5 straws from each
extender within ejaculates in ten-straw goblets were distributed to AI technicians and vet-
erinarians all over Norway. Outcomes of the inseminations were measured as 56-day non-
return rate (NRR). Postthaw sperm quality was assessed by ﬂow cytometry using propidium
iodide and Alexa 488–conjugated peanut agglutinin to assess the proportion of plasma
membrane and acrosome-intact sperm cells, respectively. In total, data from 14,125 ﬁrst
inseminations performed over a 12-month period, 7081 with Biladyl and 7044 with
SpermVital semen,were used in the statistical analyses. Therewas no signiﬁcant difference in
56-day NRR for the two semen categories, overall NRR being 72.5% and 72.7% for Biladyl and
SpermVital, respectively. The ﬂow cytometric results revealed a signiﬁcant higher level of
acrosome-intact live spermatozoa in Biladyl-processed semen compared to SpermVital
semen. The results indicate that the level of acrosome-intact live spermatozoa in the AI dose
did not affect the 56-dayNRR for the two semenprocessingmethods. In conclusion, this study
has showed that immobilized spermatozoa provide equal fertility results as standard pro-
cessed semen when AI is performed in a blinded ﬁeld trial, although the immobilizationþ47 62517601.
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F.B. Standerholen et al. / Theriogenology 84 (2015) 413–420414procedure caused increased sperm damage evaluated in vitro compared to standard semen
processing procedure.
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Artiﬁcial insemination (AI) is commonly used for a range
of domestic animals and in aquaculture. The technique can
be applied with fresh, liquid, and cryopreserved semen,
depending on species, and is the most valuable tool for
animal breeding programs and genetic improvements [1]. In
commercial animal production, fertility results are crucial to
the total economic outcome. In the cattle breeding industry,
AI is mainly applied with cryopreserved spermatozoa, a
technology developed around 1950 on the basis of the dis-
covery of glycerol being protective to sperm cells during
freezing [2]. To obtain good fertility results, AI must be
performed within a restricted number of hours before
ovulation. Therefore, new technologies that prolong the
lifetime of spermatozoa in vivo after AI will be beneﬁcial to
the industry because timing of AI relative to ovulationwill be
less critical.
Alginate gels are formedby interactions betweendivalent
ions such as Ca2þ and block structures of the guluronic acid
in the alginate polymer chain. Therefore, the formation of
alginate gels can be conducted under very mild conditions,
and have thus been commonly used for immobilization of
various types of cells [3,4]. However, immobilization in
alginate has beenmost commonly used as a starting point for
later formation of various types of capsules with a liquid
core. Several studies of encapsulation of spermatozoawithin
microcapsules are published [5–9]. These studies have used
methods resulting in particles where the spermatozoa are
located within a liquid core surrounded by a membrane.
Nebel et al. [5] reported that encapsulation was
compatible with bovine sperm survival and that negligible
sperm injury was observed during storage of encapsulated
spermatozoa at 37 C. Later, several studies have reported
that encapsulated spermatozoa maintain their fertilizing
capacity after AI [6–8], also when AIs were performed in
proestrus, i.e., early relative to ovulation [9]. The technique
has been appliedwith semen from other species such as ram
[10] and boar [11], and ﬁnally, novel systems for encapsu-
lation and release of bovine spermatozoa in capsules with a
liquid core have been described [12,13].
The SpermVital technology for immobilization and
cryoconservation of bull spermatozoa for AI has been
developed during the past decade [14] and is implemented
in large-scale production. This technology uses a funda-
mentally different approach to immobilize spermatozoa
than previously published methods as spermatozoa are
immobilized within a solid gel network made of calcium
alginate gel. Immobilizationwithin a solid gel networkmay
have advantages compared to encapsulation within cap-
sules. Using this method, movement of the immobilized
spermatozoa might be restricted because of constraints of
the gel network. This might resemble the situation in cauda
epididymis where physical limitation of movement due to
high concentrations of cells and presence of high viscositypolymers may be one of the factors that inﬂuence survival
and maintenance of functionality of spermatozoa over long
periods of time [15].
The success of bovine AI programs, regardless of semen
processing techniques, is largely dependent on the use of
good-quality semen, and it is reported that sperm charac-
teristics are correlated to differences in fertility [16].
Simultaneously evaluating postthaw viability and acro-
some integrity of spermatozoa by ﬂow cytometry is a
valuable testing tool in both research and routinework [17].
The SpermVital technology has been shown to be
applicable for AIs performed early relative to ovulation
(unpublished data); however, it is also important to know
how the semen performswhen used at normal timing of AI.
The dissolving of the gel and thereby release of sperm cells
is designed to last for at least 24 hours. Insemination
performed at conventional timing may therefore be sub-
optimal for SpermVital-processed semen because fewer
sperm cells are assumed to be available at the time of
ovulation. The question to be raised in this investigation
was whether enough sperm cells are released and capable
of fertilization at conventional timing of AI.
The aim of this study was to compare the fertilizing
capacity of semen processed with two different methods:
conventional (Biladyl) and immobilization processing (the
ﬁrst-generation SpermVital technology) [14] in a blinded
ﬁeld trial. Furthermore, the semen samples were analyzed
to reveal differences in sperm quality between the pro-
cessing techniques by assessing acrosome and plasma
membrane integrity. Moreover, the association between
these sperm quality parameters and ﬁeld fertility was
determined.
2. Materials and methods
2.1. Semen samples for insemination trial and in vitro studies
All procedures for semen processing, being in compli-
ancewith European Union Directive 88/407, were approved
by the Norwegian Food Safety Authority. The insemination
trial was not in violation of any ethical guidelines or
legislation.
During the June–August 2010 period, semen from 16
Norwegian Red (NRF) young bulls with unknown fertility
was collected and processed by the breeding company Geno
SA (Geno Breeding and AI Association, Hamar, Norway). The
bulls had a mean age of 469 days (range, 432–497) on the
ﬁrst day of semen collection. Collectionwas performed once
a week, with two separate ejaculates collected with
approximately 15 minutes of interval before pooling.
Collection continued until a minimum of 2000 doses were
produced from each bull, resulting in processing of 4 to
9 ejaculates per bull, in total 85 ejaculates. Sperm concen-
tration was estimated by spectrophotometer, and motility
was evaluated by phase-contrast microscopy before and
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below 390 million/mL was discarded.
All ejaculates were split in two aliquots (“split-sample”
design), one control processed routinely with the Biladyl
(egg yolk tris) extender (13500/0004-0006; Minitube
GmbH, Tiefenbach,Germany) and theother processedby the
experimental ﬁrst-generation SpermVital extender
(SpermVital AS, Hamar, Norway), later referred to as B and
SV, respectively. The two aliquot volumes were adjusted to
achieve equal number of semen doses with each extender,
and they were given a unique batch number for straw
printing and later identiﬁcation of results from AIs. The
semen aliquotswere diluted in a two-step procedure, with B
extender to a ﬁnal concentration of 12  106 spermatozoa/-
doseandwithSVextender toaﬁnal concentrationof25106
spermatozoa/dose. After dilution, semen was ﬁlled into
white, translucent, 0.25-mL Top Bull Straws (IMV 017011;
IMV Technologies, L’Aigle, France) and cryopreserved ac-
cording to standard procedures for B and SV processing.
Semen doses were then stored in liquid nitrogen at196 C
until ﬁnalizing quality control, quarantine, and consecutive
distribution. Only ejaculates with postthaw motility of at
least 50% in both B- and SV-extended aliquots were used in
the trials, resulting in exclusion of one ejaculate from each of
three bulls. The trial was blinded, with processing methods
applied being unidentiﬁable to the AI personnel. Straws (5
B þ 5 SV) from each ejaculate were packed in ten-straw
goblets and distributed to AI technicians and veterinarians
all over Norway for the ﬁeld trial. In total, 170 batches of
semenwere distributed (85 B and 85 SV). Accordingly, doses
from all batches, separated and identiﬁed by goblets, were
shipped to the laboratory for in vitro experiments.
In addition, semen doses from three bulls were produced
for a control in vitro experiment performed to evaluate the
possible inﬂuence of the difference in ﬁnal sperm concen-
tration between the two processing methods on outcome of
sperm quality analyses. Biladyl and SV semen were pro-
duced by split-sample of each ejaculate with 12  106 and
25  106 spermatozoa/straw for both semen extenders,
totally four batches per bull.
2.2. Staining of frozen–thawed sperm samples for ﬂow
cytometric analyses
Propidium Iodide (PI, P4864; Sigma–Aldrich, St. Louis,
MO, USA) was used to discriminate between live and dead
spermatozoa, i.e., plasmamembrane intact anddegenerated,
respectively. Lectin peanut agglutinin (PNA) from Arachis
hypogaea (peanut) conjugated with Alexa Fluor 488 (PNA–
Alexa 488, L21409; Invitrogen, Paisley, UK) was used to
identify the proportion of acrosome-intact and reacted or
degenerated spermatozoa, whereas MitoTracker Orange
CMTMRos (MO, M7510; Invitrogen) was used as a sperm
identiﬁcation probe. Stock solutions of all ﬂuorochromes
were prepared in DMSO (D-5879, Sigma–Aldrich) according
to product information. A PBS staining solution of ﬂuoro-
chromeswith stock concentration of 0.05mg/mLPNA–Alexa
488, 1.5 mM PI, and 10 mM MO was prepared. For semen
analyses, semen doses were thawed for 1 minute in a water
bath at 37 C. Thereafter, to equalize sperm concentration,
250 and 500 mL gel-dissolving medium (provided bySpermVital AS) prewarmed to 37 C was added to the B and
SV semen, respectively. Sampleswere placed on a tilt tray for
5 minutes in an incubator at 37 C before further incubation
for 3 hours at 37 C. After incubation, the samples were
transferred to a heating block at 37 C, and 30 mL semenwas
added to 470 mL prewarmed staining solution to a ﬁnal
concentration of w2 million sperm cells/mL and a ﬁnal
concentration of staining solution of 50 rg/mL of PNA–Alexa
488, 7.48 mM PI, and 0.15 mM MO. Samples were then incu-
bated on the heat block at 37 C for 10 minutes before ﬂow
cytometric analysis. Semen fromthree strawsperbatchwere
stained and analyzed in two replicates by ﬂow cytometry.
2.3. Flow cytometric assessment
Measurements were performed on a Cell Lab Quanta SC
MPL ﬂow cytometer (Beckman Coulter, Fullerton, CA, USA),
later referred to as Quanta. The ﬂow cytometry–generated
data were analyzed in Cell Lab Quanta SC MPL Analysis
software program (Beckman Coulter) and then exported to
Microsoft Ofﬁce Excel (Microsoft, Redmond, WA, USA) for
statistical analysis. The instrument was checked daily for
optical alignment by running Flow-Check beads (6605359;
Beckman Coulter). An unstained sperm sample was
included as the negative control. Electronic volume and
side scatter signals were used to identify spermatozoa,
whereasMOwas used as an additional sperm identiﬁcation
probe. The three dyes were excited using a 488 nm argon
laser. Peanut agglutinin–Alexa 488 and MO ﬂuorescence
emission was detected using a 510 to 540 nm band pass
ﬁlter (FL1) and a 560 to 590 nm band pass ﬁlter (FL2),
respectively, whereas PI ﬂuorescence was detected using a
670 nm long pass ﬁlter (FL3). Compensationwas performed
before collection of data with unstained spermatozoa and
spermatozoa stained singularly with PNA–Alexa 488, MO,
and PI. The regions were set and gating was performed as
described by Standerholen et al. [18] to exclude debris
particles and reveal percentages of (1) acrosome-intact
dead (AID) spermatozoa, (2) acrosome-reacted dead
(ARD) spermatozoa, (3) acrosome-intact live (AIL) sper-
matozoa, and (4) acrosome-reacted live (ARL) spermatozoa.
2.4. Statistical analyses
Data on 56-day nonreturn rate (NRR) for the ﬁrst
inseminations were compared for B and SV semen. Animals
with inseminations repeated within 3 days after the ﬁrst AI
were excluded from the analyses. The possible effects on
NRR were analyzed by the General Linear Models Proce-
dure software, using Statistical Analysis System (SAS)
version 9.3 (SAS 2002–2010) for Microsoft Windows (SAS
Institute Inc., Cary, NC, USA).
Least-square analysis was used to estimate the effect of
bull or batch, month of AI, parity of the females, and semen
processing on NRR by the following model:
Yijklmn ¼ mþ li þ pk þ tl þ vm þ ejklmn
where:
Yijklmn ¼ observation per heifer/cow;
m ¼ overall mean;
Table 1
Least-square means for 56-day nonreturn rate (NRR) for artiﬁcial
inseminations (AIs) with Biladyl- (B) and SpermVital- (SV) processed
semen within parity (parity 0: heifers; parity 4: 4 lactations) with cor-
responding number of AIs.
Parity B SV
NRR (%) No. of AIs NRR (%) No. of AIs
0 77.4 2516 77.3 2436
1 69.2 1928 70.2 2005
2 71.2 1251 71.7 1228
3 72.0 669 71.5 681
4 73.4 717 71.9 694
Total 72.5 7081 72.7 7044
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i ¼ 1 to 166;
pk ¼ effect of month of AI, k ¼ 1 to 12;
tl ¼ effect of parity, l ¼ 0 to 4;
vm ¼ effect of semen processing, m ¼ 1,2;
ejklmn ¼ random error.
Statistical analyses of the ﬂow cytometry–generated
postthaw sperm quality were performed using JMP soft-
ware, version 8 for Microsoft Windows (SAS Institute, Inc.).
Percentages of AID, ARD, AIL, and ARL spermatozoa are
presented as mean (standard deviation) and by 95% conﬁ-
dence interval (CI) plot within the semen extender. Variation
in the proportion of spermatozoa that potentially may
fertilize after AI, AIL (%), were compared and tested with
nested (hierarchy) ANOVA (bull, straw, replicate, processing)
to reveal the contributed variation by the explanatory vari-
ables to the total variation explained by the statistical model.
Because of the difference inﬁnal spermconcentration of B
and SV semen, the percent AIL data were transformed to
millions of AIL spermatozoa per dose (million/straw) before
testing a possible effect of the proportion of the potential
fertilizing spermatozoapostthawonoutcomeof AI. A paired t
test was used to make paired comparisons of differences in
AIL spermatozoa (million/straw) between B and SV semen
sampleswithin ejaculate and bull. Results from this testwere
described by 95% CI and presented in a CI plot. If the CI in the
plot contained the reference line at zero, then the means of
the two samples, SV and B, from the same bull were not
regardedassigniﬁcantlydifferent. TheCIplotwasalsoused to
reveal if these pairwise differences were signiﬁcant between
individuals. The F test (the var.test function) was performed
using R, version 3.1.0 (http://www.r-project.org/), to analyze
whether the variation in AIL spermatozoa (million/straw)
between batcheswithin bull was different between B and SV
semen, i.e., within-bull variation for B and SV.
Moreover, testing for the possible effect of proportion of
AIL spermatozoa (million/straw) on outcome of AI
measured as 56-day NRR, was analyzed using the general
linear model procedure software, using SAS version 9.3
(SAS 2002–2010) for Microsoft Windows (SAS Institute
Inc.) by the following model:





Yijk ¼ observation per heifer/cow;
m ¼ overall mean;
i ¼ effect of month of AI, k ¼ 1 to 12;
ti ¼ effect of parity, l ¼ 0 to 4;
b1 ¼ partial regression of AIL (million/straw) on NRR.
eijk ¼ random error.
Outcomes with probability values less than 0.05 were
considered statistically signiﬁcant for all analyses performed.
3. Results
3.1. Field fertility
The motility analyses from the 170 batches included in
the study showed no difference in percentage postfreezemotility for B and SV semen, being 55 (4), mean (standard
deviation) for both. Nonreturn rates (56 days) were
obtained for AIs performed during 12 months from the
start of the trial, giving data on a total of 14,125 ﬁrst
inseminations from 166 batches, 7081 with B and 7044
with SV semen, Table 1. There was a signiﬁcant inﬂuence of
both month of AI, bull, and parity of the females on 56-day
NRR. Most AIs were performed during the months
September through December, representing 87.4% and
87.8% of total AIs for B and SV, respectively. The number of
AIs with B and SV was well balanced within month,
maximum difference being 0.3% of total number of AIs per
semen treatment. Artiﬁcial inseminations performed in the
months of June, August, and September resulted in signif-
icant superior NRR in comparison with the other months,
representing 15.5% and 15.0% of all AIs for B and SV,
respectively. All 16 bulls had a well-balanced number of AIs
within semen treatment. Artiﬁcial inseminations from
three bulls resulted in signiﬁcantly higher NRR compared
to the remaining 13 bulls. Parity of the females represented
highly signiﬁcant (P < 0.01) inﬂuence on the NRR (Table 1).
There was, however, no signiﬁcant difference in 56-day
NRR for the two semen categories, neither overall or
when statistical analyses were performed within month of
AI, bull or parity. Overall NRRs presented as least-square
means were 72.5% and 72.7% for B and SV, respectively.
When the variable bull in the least squares analysis was
replaced by batch (i ¼ 1–166), the possible inﬂuence of
variation between batches on NRR was estimated. There
was no signiﬁcant inﬂuence of batch variation, neither
when statistical analyses were performed overall nor
within semen processing methods.
3.2. Plasma membrane and acrosome integrity assessed by
ﬂow cytometry
Semen samples from all 170 batches assessed for plasma
membrane and acrosome integrity resulted in mean AID,
ARD, AIL, and ARL spermatozoa for the B semen batches
being 25.0% (0.06), 23.7% (0.07), 49.3% (0.11), and 1.5%
(0.01), respectively. For the SV samples, corresponding
values were 27.1% (0.07), 33.9% (0.08), 36.0% (0.12), and
2.4% (0.01). Mean values with 95% CI are presented in
Figure 1.
These results show a signiﬁcant effect (P < 0.0001) of
processing method, with the SV technology resulting in a
lesser proportion of percent AIL spermatozoa than for
Fig. 1. (A–D) 95% Conﬁdence interval plot with upper and lower conﬁdence limits and mean values measured as (A) percentages of acrosome-intact dead
spermatozoa (% AID), (B) acrosome-reacted dead spermatozoa (% ARD), (C) acrosome-intact live spermatozoa (% AIL), and (D) acrosome-reacted live spermatozoa
(% ARL) for 170 batches of Biladyl (B) and SpermVital (SV) semen.
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method explained 19.5% of the total variation in percentage
of AIL spermatozoa. Moreover, there was a signiﬁcant effect
(P < 0.0001) of bull, explaining 17.0% of the total variation
in measured percent AIL spermatozoa. Neither differences
between straws within batch nor replicate within straw
affected percentages of AIL spermatozoa signiﬁcantly.
The control experiment, performed to evaluate the
possible inﬂuence of the difference in sperm concentra-
tions on the outcome of sperm quality analyses, showed
that there were no signiﬁcant differences in percentages of
AIL spermatozoa between semen samples processed with
12 million sperm/straw or with 25 million sperm/straw
within processing method. However, percentages of AIL
spermatozoa were signiﬁcantly lower in SV semen, 28.0%
(5.3) and 31.3% (5.9), than those in B semen, 46.4% (4.4) and
47.9% (3.6), in doses with 12 and 25 million sperm/straw,
respectively.Fig. 2. 95% Conﬁdence interval plot with upper and lower conﬁdence limits
and mean values measured as millions of acrosome-intact live (AIL) sper-
matozoa per straw for each bull (n ¼ 16) on the basis of data from a paired t
test measured as differences (D) in AIL (million/straw) spermatozoa between
SpermVital (SV) and Biladyl (B) semen samples (D AILSV-B). The ﬁgure shows
the reference line at zero used to decide if this pairwise difference was
signiﬁcantly different within individuals.3.3. Variation in percentages of AIL spermatozoa between B
and SV semen in association to AI outcome
When comparing the AIL data transformed to millions of
spermatozoa per straw, the CI for paired difference in AIL
spermatozoa (million/straw) between SV and B (DAILSV-B)
semen showed a signiﬁcant difference between the
processing methods within bull for nine of the 16 bulls
(Fig. 2). Seven of the paired differences are crossing the
reference line at zero (Fig. 2) and therefore considered not
signiﬁcantly different. In addition, the results showed that
there was a signiﬁcant difference in DAILSV-B spermatozoa
between some of the individuals. As an example, bulls 2 and5 show a signiﬁcant difference in DAILSV-B (million/straw)
spermatozoa, but the DAILSV-B (million/straw) spermatozoa
for bull 1 is not signiﬁcantly different from bull 5. The results
also showed that there was a variation in width of the CIs,
indicating variation in DAILSV-B (million/straw) spermatozoa
across the individuals. Further, the F test showed that the
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was signiﬁcant higher than that for B semen, i.e., higher
variance between batches within individual and also
between bulls processed by SpermVital technology
(F82.82 ¼ 5.14, P < 0.0001).
The level of AIL spermatozoa (million/straw) did, how-
ever, not inﬂuence the 56-day NRR signiﬁcantly when
included as an explanatory variable in the general linear
models procedure, neither overall nor within semen pro-
cessing method.
4. Discussion
The ﬁeld fertility results measured as 56-day NRR were
equal for AIs with standard B and immobilized SV semen in
this trial. Because the trial had a blinded design, i.e., semen
processing of AI dose was unknown to the technicians and
veterinarians, the AIs were performed at conventional
timing relative to ovulation on the basis of estrous signs
and observations thereof. Recommendation in Norway is to
inseminate during the second half of the estrus and the ﬁrst
six hours after termination of estrous signs, theoretically
being the period from 9 to 24 hours after the onset of estrus
and 6 to 21 hours before ovulation. The SpermVital tech-
nology has been developed to make timing of AI less
critical, by extending sperm survival at body temperature
and to allow a gradual release of spermatozoa over time
after AI. The question raised in this investigation was
whether enough sperm cells are released and capable of
fertilization at conventional timing of AI. Previous publi-
cations on encapsulated spermatozoa have conﬂicting
results concerning AI on animals in estrus. In some publi-
cations, the authors conclude that encapsulated sperm cells
are capable of fertilizing in vivo but are not favored by
insemination at conventional time [7,19], whereas others
report improved fertility at optimum time using encapsu-
lated spermatozoa [8].
The SpermVital technology is using a quite different
approach than encapsulation described previously, as
sperm cells are embedded in an alginate gel, which will
gradually dissolve and release sperm cells over an extended
period of time [14]. The number of sperm cells released per
hour in utero and the dissolving period are not exactly
known. Cows have been slaughtered after AI with SV semen
showing alginate gel residues being present in utero
approximately 24 hours after AI (unpublished data).
Several in vitro studies applying forced dissolution of the
gel over different time periods have reported continuous
and gradually sperm relase during the dissolving period
(unpublished data). This is in contrast to encapsulation
where sperm cells are located in a liquid core surrounded
by an alginate capsule [7]. On capsule rupturing, all sperm
cells are released immediately, and only asynchronous
rupturing of capsules will ensure extended sperm release.
Another difference is that encapsulated sperm cells are in a
liquid environment, thus not physically immobilized, and
possibly precapacitated because of the encapsulation pro-
cedure [8]. In theory, the gradual dissolution of SV semen
should ensure availability of a limited population of sper-
matozoa ready to fertilize also when AI is performed at
optimum timing. The fertility data from this study conﬁrmsthat SV semen shows equal performance to conventional
semen when inseminated at estrus.
In this study, heifers showed signiﬁcantly higher
fertility rates than cows. Moreover, the month at which the
AIs were performed signiﬁcantly inﬂuenced NRR. These
results are in compliance with fertility recording in Norway
[20–22]. Fertility in NRF is high compared to other cattle
breeds [23] mainly because of having emphasized fertility
performance in the NRF breeding program for decades
[24,25]. Obtaining equal NRR with immobilized sperma-
tozoa in comparison to standard processed semen is thus a
good demonstration of the technology’s performance, as
improvement of already high fertility rates is difﬁcult to
report.
The fact that SV semen contained about twice the
number of sperm cells as standard semen might have
inﬂuenced the results, as it is known that fertility potential
of a semen sample is affected by the number of sperma-
tozoa per AI dose [26,27]. An increasing number of sper-
matozoa per AI dose will improve fertility up to a certain
threshold, when the maximum fertility level of the bull is
reached and where it is no longer possible to compensate
for the differences in fertility between the males by
increasing the number of spermatozoa per AI dose [27,28].
Previously, it has been shown with conventional semen
that AIs with 12 million sperm cells/dose perform similarly
to AIs with 18 million/dose [29]. Consequently, the AI dose
of 12 million sperm/straw used for B semen in the present
study should be regarded as above the threshold of
maximum fertility [26,27], at least for most bulls. Also,
12 millions were chosen because this was the standard
sperm number per dose used for NRF young bulls used in
this study (Geno SA, Hamar, Norway). However, the SV
semen was produced with a higher sperm concentration
because of the theory that this semen is dissolved gradually
after insemination, i.e., to ensure enough available sper-
matozoa throughout the dissolving period. Dissolution of
the alginate gel and thereby sperm release is believed to
last for at least 24 hours. Additionally, the higher number of
spermatozoa per AI dose was also a compensation for the
reduced postthaw sperm survival caused by the immobi-
lization procedure. In contrast to experiments on encap-
sulation ﬁnding no or minimal sperm injuries due to the
technology [5,6,30], immobilization in combination with
cryopreservation caused increased sperm death compared
to conventional semen processing injuries as reported by
in vitro analyses in the present study.
The ﬁnal sperm concentration after processing of semen
might have had an effect on the postthaw sperm quality. In
the present study, SV semen had a sperm concentration of
about the twice that of B semen. The control experiment,
however, conﬁrmed that the difference in sperm concen-
tration between B and SV semen did not inﬂuence the
postthaw proportion of AIL spermatozoa. Thus, the observed
differences in sperm quality between B and SV semen should
therefore solely be inﬂuenced by the processing method.
The ANOVA test showed that there was a signiﬁcant ef-
fect of processing method, as the ﬁrst-generation SV tech-
nology used for immobilization and cryoconservation in this
study resulted in a lower proportion of percent AIL sper-
matozoa than semen processed by the standard method. In
F.B. Standerholen et al. / Theriogenology 84 (2015) 413–420 419accordance with other studies, bull signiﬁcantly affected the
proportion of AIL spermatozoa (%) postthaw [31].
The CI for paired difference in AIL spermatozoa (mil-
lion/straw) between B and SV semen showed that there was
avariation inwidth of the conﬁdence interval, indicating that
different bulls show a different tolerance to the two semen
processing methods. In fact, the result indicates that semen
from some bulls tolerates immobilization and cryopreser-
vation better than other ones, a fact that must be taken into
account in further improvement of the technology.
No association was found between the in vitro sperm
quality results measured as AIL spermatozoa (million/straw)
and the fertility results. This result is in accordance with
earlier studies showing that in vitro assessment of viability
and acrosome integrity had no correlation to ﬁeld fertility
[17,31,32], whereas others have shown an association
[16,33,34]. The reason for these conﬂicting results could be
due to the relatively high number of sperm cells in the
semen samples of both B and SV used for AI, i.e., there are
still enough sperm cells capable of fertilizing the egg even in
the samples with the poorest quality in this study. It is also
possible that assessment and characterization of sperm
subpopulations will elucidate association of sperm quality
with fertility. As an example, Birck et al. [34] found that the
percentage of acrosome reaction inducibility in the live
sperm population appeared to be a better sperm quality
parameter for prediction of bull fertility. It is also possible
that including a combination of several sperm quality
parameters might be a good predictive model for ﬁeld
fertility, as others have claimed earlier [33].4.1. Conclusions
The present study shows that semen processed by
SpermVital immobilization technology performs equally to
standard processed semen when AI is performed at con-
ventional time, although the immobilization procedure
caused increased sperm damage evaluated in vitro. The fact
that the AI was performed at conventional timing is
regarded as suboptimal for SpermVital-processed semen
compared to Biladyl-processed semen on the basis of the
theory of gradually dissolving of the gel and thereby
gradually release of the spermatozoa in a SpermVital dose.
SpermVital AS will continue to develop the immobilization
technology to improve sperm quality and production
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